Featured Research

from universities, journals, and other organizations

Protein Protects Against Degeneration Of Neurons In Fruit Flies

Date:
December 25, 2001
Source:
Howard Hughes Medical Institute
Summary:
Researchers have genetically manipulated fruit flies so that the flies produce a human protein that protects against the degeneration of neurons similar to those affected in Parkinson’s disease.

December 21, 200 -- Researchers have genetically manipulated fruit flies so that the flies produce a human protein that protects against the degeneration of neurons similar to those affected in Parkinson’s disease.

Related Articles


The protective protein, called a chaperone, suppresses the toxicity of a-synuclein, a protein associated with Parkinson’s disease in humans. Progressive loss of dopaminergic neurons produces the neurological symptoms of Parkinson’s disease. Chaperone proteins normally aid in proper folding of proteins and are involved in protecting against cellular stresses.

The findings were reported in the December 21, 2001, issue of Science by Howard Hughes Medical Institute investigator Nancy M. Bonini and colleagues at the University of Pennsylvania School of Medicine.

In Parkinson’s disease and select other neurodegenerative disorders, a-synuclein is a key component of inclusion bodies, known as Lewy bodies, that are characteristic of these diseases. Mutations in a-synuclein have been found in some inherited forms of Parkinson’s disease. Working with the fruit fly Drosophila, researchers had previously produced similar pathological effects of dopaminergic neuron loss, by engineering a-synuclein over-production in flies.

In previous studies, Bonini and her colleagues had shown that the Hsp70 chaperone protected against neurotoxicity in a Drosophila model of a neurodegenerative disorder in which pathogenic human proteins with long runs of polyglutamine caused the destruction of neurons.

"We had shown that Hsp70 was a very powerful suppressor of polyglutamine toxicity in Drosophila, so we theorized that a chaperone that interfered with one neurodegenerative disease might interfere with another," said Bonini.

In their experiments, the scientists showed that flies engineered to express the gene for human Hsp70 along with a-synuclein showed survival of dopaminergic neurons that normally degenerated upon expression of a-synuclein alone.

"We observed that the inclusion bodies were still present in the neurons," said Bonini. "But the toxicity of a-synuclein was greatly diminished. This told us that the presence of the Hsp70 was reducing the toxicity of the a-synuclein, despite the continued presence of inclusions."

The researchers showed that by experimentally interfering with a Drosophila counterpart of human Hsp70, they enhanced the toxicity of a-synuclein, suggesting a critical role for chaperones in the dopaminergic neurons. Moreover, loss of chaperone activity caused some loss of dopaminergic neurons in the flies in the absence of a-synuclein. This loss of neurons was similar to the damage caused by a-synuclein alone.

The neuroprotective effect of Hsp70 might stem from the chaperone’s ability to correct an abnormal and toxic conformation of a-synuclein and render it non-toxic. Alternatively, a-synuclein’s toxicity might arise from its ability to bind to Hsp70 and prevent it from doing its normal job. Augmenting levels of Hsp70, as the scientists did in their experiments, might correct that deficit and overcome the toxic effect of loss of chaperone function.

In addition to their studies in flies, the scientists explored whether Hsp70 might be found in Lewy body inclusions in the brain tissue of humans who had Parkinson’s disease. "When we examined brain tissue from Parkinson’s patients, as well as patients with other diseases associated with abnormal a-synuclein aggregation, we could see staining for Hsp70 and for another chaperone, Hsp40," said Bonini. "This finding makes us hopeful that the protective effect of chaperones we found in flies might also be applicable to humans."

Bonini said she hopes that her findings will encourage more research on the role of chaperones in mammalian models of disease. "If Hsp70’s role of protecting against a-synuclein toxicity is confirmed in mammals, an important step would be to pursue drugs that upregulate the stress response that produces these chaperones, and determine whether they will protect neurons," she said.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Protein Protects Against Degeneration Of Neurons In Fruit Flies." ScienceDaily. ScienceDaily, 25 December 2001. <www.sciencedaily.com/releases/2001/12/011221081005.htm>.
Howard Hughes Medical Institute. (2001, December 25). Protein Protects Against Degeneration Of Neurons In Fruit Flies. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2001/12/011221081005.htm
Howard Hughes Medical Institute. "Protein Protects Against Degeneration Of Neurons In Fruit Flies." ScienceDaily. www.sciencedaily.com/releases/2001/12/011221081005.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins